Pulmonary embolism, transient ischaemic attack and thrombocytopenia after the Johnson & Johnson COVID-19 vaccine

As with past illnesses, an approach has been taken to vaccinate the population and halt the spread of COVID-19. On 13 April 2021, the US Food and Drug Administration called for a halt in the administration of the Johnson & Johnson (J&J) COVID-19 vaccine due to reports of thrombosis and throm...

Descripción completa

Detalles Bibliográficos
Autores principales: Malik, Bilal, Kalantary, Atefeh, Rikabi, Kamal, Kunadi, Arvind
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280905/
https://www.ncbi.nlm.nih.gov/pubmed/34261635
http://dx.doi.org/10.1136/bcr-2021-243975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280905/
https://www.ncbi.nlm.nih.gov/pubmed/34261635
http://dx.doi.org/10.1136/bcr-2021-243975

Ejemplares similares